Table 3.
(a) Precursor polymer characterization by GPCa
| ||||
---|---|---|---|---|
sample | monomers | Mn Target g mol−1 | GPC Mn g mol−1 | Mw/Mn |
E1:P9 | ethyl-propyl | 3500 | 11 600 | 1.08 |
E1:P2 | ethyl-propyl | 3400 | 7000 | 1.34 |
E1:P1 | ethyl-propyl | 3000 | 11 000 | 1.08 |
E2:P1 | ethyl-propyl | 3500 | 10 200 | 1.15 |
E9:P1 | ethyl-propyl | 3400 | 7600 | 1.30 |
M9:E1 | methyl-ethyl | 3400 | 13 600 | 1.10 |
M1:E1 | methyl-ethyl | 3500 | 14 400 | 1.08 |
M1:E9 | methyl-ethyl | 3500 | 14 500 | 1.08 |
M9:P1 | methyl-propyl | 3400 | 15 300 | 1.07 |
M1:P1 | methyl-propyl | 3600 | 15 900 | 1.07 |
M1:P9 | methyl-propyl | 3700 | 14 700 | 1.07 |
(b) Characterization of the antimicrobial copolymers by biological assaysb
| |||||||
sample | monomer | Mn. Target g mol−1 | MIC90
μgmL−1
|
HC50 μg mL−1 | selectivty
|
||
E. coli | S. aureus | E. coli | S. aureus | ||||
| |||||||
Propyl_3k | propyl | 3000 | 6.25 | 15 | 50 | 8.0 | 3.3 |
E1:P9 | ethyl:propyl | 3500 | 15 | 15 | <50 | <3.3 | <3.3 |
E1:P2 | ethyl:propyl | 3400 | 15 | 15 | <50 | <3.3 | <3.3 |
E1:P1 | ethyl:propyl | 3000 | 100 | 200 | 1000 | 10 | 5.0 |
E2:P1 | ethyl:propyl | 3500 | >200 | 200 | >2000 | 10 | >10 |
E9:P1 | ethyl:propyl | 3400 | >200 | 50 | 500 | <2.5 | 10 |
Ethyl_3k | ethyl | 3000 | 50 | 50 | 1400 | 28 | 28 |
| |||||||
Methyl_3k | methyl | 3000 | >200 | 100 | 2000 | <10 | 20 |
M9:E1 | methyl-ethyl | 3400 | >200 | 6.25 | 700 | <3.5 | 112 |
M1:E1 | methyl-ethyl | 3500 | >200 | 12.5 | 1200 | <6.0 | 96 |
M1:E9 | methyl-ethyl | 3500 | >200 | 12.5 | 1500 | <7 | 120 |
Ethyl_3k | ethyl | 3000 | 50 | 50 | 1400 | 28 | 28 |
| |||||||
Methyl_3k | methyl | 3000 | >200 | 100 | 2000 | 10 | 20 |
M9:P1 | methyl-propyl | 3400 | >200 | <3.75 | >2000 | 10 | >533 |
M1:P1 | methyl-propyl | 3600 | >200 | <3.75 | >2000 | 10 | >533 |
M1:P9 | methyl-propyl | 3700 | >200 | <3.75 | >2000 | 10 | >533 |
Propyl_3k | propyl | 3000 | 6.25 | 15 | 50 | 8.3 | 3.3 |
DMF, 0.01 mol L−1 LiCl, PS standards.
Inhibitory activity towards bacterial growth of E. coli and S. aureus bacteria (MIC90 = minimal inhibitory concentration preventing 90% bacterial growth) and hemolytic activity towards red blood cells (HC50 = concentration lysing 50% of blood cells). Sample labeling: e.g., E1:P9 is a copolymer with 10 mol% ethyl and 90 mol% propyl monomer.